Evgeny Barinov, Deputy CEO of NANOLEK for Finance and Digital Technologies, took part in the Eighth forum “Pharma CFO 2019”, which was held in Moscow on November 21-22, 2019.

The forum brought together CFO’s of the leading providers fr om the pharmaceutical industry only - manufacturers, distributors and pharmacy chains.

The organizers traditionally conducted a survey among the forum participants and received an interesting summary. The vast majority believe e.g. that a CFO should have diverse experiences in his or her portfolio:

58% of respondents said that moving to a pharmaceutical company from other sectors is possible, and 39% believe that such a decision is reasonable on top of all. And only 3% of respondents advocate hiring of professionals with a “pharma background only”.

A part of the panel discussion attended by Yevgeny Barinov was dedicated to debates on the pricing procedure for life-saving and essential drugs (LSED), price registration issues, legislation governing management of prices for LSED as well as practice of re-registration of drugs produced and registration of new ones.

Such meetings are particularly useful when held on a regular basis and attended by representatives of entities at different levels. Figuratively speaking, there is a big boat called “health” wh ere several members of the team are sitting. And such meetings specifically help all participants reach an agreement about further steps and direction.